Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Virax Biolabs Group Ltd (NASDAQ: VRAX) closed the day trading at $0.81 down -8.32% from the previous closing price of $0.88. In other words, the price has decreased by -$8.32 from its previous closing price. On the day, 0.55 million shares were traded. VRAX stock price reached its highest trading level at $0.9998 during the session, while it also had its lowest trading level at $0.7813.
Ratios:
For a better understanding of VRAX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.13 and its Current Ratio is at 7.27. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $3.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRAX now has a Market Capitalization of 3517422 and an Enterprise Value of -325102. For the stock, the TTM Price-to-Sale (P/S) ratio is 351.58 while its Price-to-Book (P/B) ratio in mrq is 0.62. Its current Enterprise Value per Revenue stands at -51.351 whereas that against EBITDA is 0.055.
Stock Price History:
The Beta on a monthly basis for VRAX is 1.66, which has changed by -0.28318584 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, VRAX has reached a high of $9.00, while it has fallen to a 52-week low of $0.74. The 50-Day Moving Average of the stock is -12.09%, while the 200-Day Moving Average is calculated to be -45.01%.
Shares Statistics:
Over the past 3-months, VRAX traded about 93.65K shares per day on average, while over the past 10 days, VRAX traded about 255140 shares per day. A total of 4.34M shares are outstanding, with a floating share count of 4.05M. Insiders hold about 6.63% of the company’s shares, while institutions hold 6.71% stake in the company. Shares short for VRAX as of 1752537600 were 23089 with a Short Ratio of 0.25, compared to 1749772800 on 20758. Therefore, it implies a Short% of Shares Outstanding of 23089 and a Short% of Float of 0.58999998.
Earnings Estimates
The firm’s stock currently is rated by 1 analysts. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.34 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.48 and -$1.48 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$1.01, with 1.0 analysts recommending between -$1.01 and -$1.01.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $10k. There is a high estimate of $10k for the next quarter, whereas the lowest estimate is $10k.
Based on 1 analysts’ estimates, the company’s revenue will be $40k in the next fiscal year. The high estimate is $40k and the low estimate is $40k.
